MktsMarkets

Biogen Inc.
NASDAQ: BIIBKey statistics
BIIB News
Stories mentioning BIIB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,477,800 | 2,279,400 | 2,534,700 | 2,645,500 | 2,431,000 | 2,454,700 | 2,465,800 | 2,464,900 |
| Cost of Goods Sold | 661,000 | 495,500 | 674,400 | 605,000 | 629,300 | 583,500 | 638,700 | 546,000 |
| Gross Profit | 1,816,800 | 1,783,900 | 1,860,300 | 2,040,500 | 1,801,700 | 1,871,200 | 1,827,100 | 1,918,900 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 607,300 | 682,500 | 594,800 | 583,800 | 572,500 | 680,000 | 588,400 | 553,800 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | 37,900 | 37,200 | 31,600 | 32,300 | 23,900 | 18,500 | 11,600 | 20,100 |
| Interest Expense | 67,600 | 67,500 | 67,400 | 72,600 | 60,000 | 60,000 | 59,800 | 61,300 |
| Other Expense | (1,100) | (39,700) | 15,800 | (3,300) | 2,500 | 8,000 | (800.00) | (2,000) |
| Pretax Income | 377,700 | (56,000) | 557,300 | 744,000 | 311,200 | 291,500 | 451,000 | 698,700 |
| Tax Provision | 58,200 | (7,100) | 90,800 | 109,200 | 70,700 | 24,800 | 62,500 | 115,100 |
| Net Income (Loss) | 319,500 | (48,900) | 466,500 | 634,800 | 240,500 | 266,700 | 388,500 | 583,600 |
| Earnings Per Share (Basic) | 2.17 | (0.33) | 3.18 | 4.33 | 1.65 | 1.83 | 2.67 | 4.01 |
| Earnings Per Share (Diluted) | 2.15 | (0.33) | 3.17 | 4.33 | 1.64 | 1.83 | 2.66 | 4.00 |
| Weighted Average Shares Outstanding (Basic) | 147,200 | 146,500 | 146,600 | 146,500 | 146,100 | 145,600 | 145,700 | 145,600 |
| Weighted Average Shares Outstanding (Diluted) | 148,400 | 147,100 | 147,100 | 146,700 | 146,600 | 145,900 | 146,100 | 145,900 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BIIB
Biogen Inc. (NASDAQ: BIIB) is a stock listed on the Nasdaq Stock Market under the ticker symbol BIIB. It last traded at $250.79 (Nov 17, 2026, 4:00 PM ET), down 0.3% on the day. That gives Biogen a market capitalisation of $37.0B and a price-to-earnings ratio of 106.5.
Over the past 52 weeks BIIB has traded between $160.36 and $261.00.
Revenue for the quarter ended Mar 31, 2026 was $2.5B; net income $319.5M. Revenue was up 1.9% from $2.4B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.5B | $319.5M | 12.9% |
| Dec 31, 2025 | $2.3B | -$48.9M | -2.1% |
| Sep 30, 2025 | $2.5B | $466.5M | 18.4% |
| Jun 30, 2025 | $2.6B | $634.8M | 24.0% |
From Biogen’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…